tm
Seeing Is Believing
tm
Seeing Is Believing
Neoleukin Therapeutics's activity chart (see below) currently has 29 price targets and 34 ratings on display.
Analysts average stock forecasts to be materialized ratio is 56.52% with an average time for these price targets to be met of 286.17 days.
Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 09-May-2023. First documented stock forecast 17-Mar-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Mar-2023
$7.6
$-7.5 (-49.67%)
3 years 5 months 22 days ago
(09-May-2023)
1/3 (33.33%)
$-10.2 (-57.30%)
218
Hold Since 16-Nov-2022
3 years 11 months 15 days ago
(16-Nov-2022)
1/1 (100%)
$-130.4 (-54.24%)
584
Buy Since 05-Jan-2021
$18
$2.9 (19.21%)
$360
3 years 11 months 16 days ago
(15-Nov-2022)
1/2 (50%)
$9.5 (111.76%)
167
Buy Since 06-Jul-2022
$20
$4.9 (32.45%)
$200
3 years 11 months 16 days ago
(15-Nov-2022)
0/2 (0%)
$11.5 (135.29%)
Hold Since 15-Nov-2022
$100
3 years 11 months 16 days ago
(15-Nov-2022)
1/1 (100%)
$-122.2 (-55.00%)
643
What is NLTX (Neoleukin Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on NLTX (Neoleukin Therapeutics)?
Which analyst has the most public recommendations on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most bullish on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most reserved on NLTX (Neoleukin Therapeutics)?
